222 related articles for article (PubMed ID: 17640059)
21. Connexin 32 down-regulates the fibrinolytic factors in metastatic renal cell carcinoma cells.
Hagiwara H; Sato H; Shirai S; Kobayashi S; Fukumoto K; Ishida T; Seki T; Ariga T; Yano T
Life Sci; 2006 Apr; 78(19):2249-54. PubMed ID: 16289236
[TBL] [Abstract][Full Text] [Related]
22. Functional significance of erythropoietin in renal cell carcinoma.
Morais C; Johnson DW; Vesey DA; Gobe GC
BMC Cancer; 2013 Jan; 13():14. PubMed ID: 23305401
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic stabilization of hypoxia-inducible transcription factors protects developing mouse brain from hypoxia-induced apoptotic cell death.
Trollmann R; Richter M; Jung S; Walkinshaw G; Brackmann F
Neuroscience; 2014 Oct; 278():327-42. PubMed ID: 25162122
[TBL] [Abstract][Full Text] [Related]
24. JNK2 up-regulates hypoxia-inducible factors and contributes to hypoxia-induced erythropoiesis and pulmonary hypertension.
Sala MA; Chen C; Zhang Q; Do-Umehara HC; Wu W; Misharin AV; Waypa GB; Fang D; Budinger GRS; Liu S; Chandel NS; Schumacker PT; Sznajder JI; Liu J
J Biol Chem; 2018 Jan; 293(1):271-284. PubMed ID: 29118187
[TBL] [Abstract][Full Text] [Related]
25. Cellular localization of erythropoietin gene transcription.
Lacombe C; Da Silva JL; Bruneval P; Salzmann JL; Casadevall N; Camilleri JP; Bariety J; Varet B; Tambourin P
Adv Exp Med Biol; 1989; 271():69-74. PubMed ID: 2486290
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin stimulates proliferation of human renal carcinoma cells.
Westenfelder C; Baranowski RL
Kidney Int; 2000 Aug; 58(2):647-57. PubMed ID: 10916088
[TBL] [Abstract][Full Text] [Related]
27. Hypoxia Signaling Cascade for Erythropoietin Production in Hepatocytes.
Tojo Y; Sekine H; Hirano I; Pan X; Souma T; Tsujita T; Kawaguchi S; Takeda N; Takeda K; Fong GH; Dan T; Ichinose M; Miyata T; Yamamoto M; Suzuki N
Mol Cell Biol; 2015 Aug; 35(15):2658-72. PubMed ID: 26012551
[TBL] [Abstract][Full Text] [Related]
28. Leukemia kidney infiltration can cause secondary polycythemia by activating hypoxia-inducible factor (HIF) pathway.
Osumi T; Awazu M; Fujimura E; Yamazaki F; Hashiguchi A; Shimada H
Eur J Pediatr; 2013 Jun; 172(6):829-32. PubMed ID: 23677251
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-inducible factor-2 (HIF-2) regulates hepatic erythropoietin in vivo.
Rankin EB; Biju MP; Liu Q; Unger TL; Rha J; Johnson RS; Simon MC; Keith B; Haase VH
J Clin Invest; 2007 Apr; 117(4):1068-77. PubMed ID: 17404621
[TBL] [Abstract][Full Text] [Related]
30. Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: a role for IL-6.
Ramadori P; Ahmad G; Ramadori G
Lab Invest; 2010 Sep; 90(9):1306-24. PubMed ID: 20458283
[TBL] [Abstract][Full Text] [Related]
31. Hypoxia-inducible factor 1alpha expression in renal cell carcinoma analyzed by tissue microarray.
Lidgren A; Hedberg Y; Grankvist K; Rasmuson T; Bergh A; Ljungberg B
Eur Urol; 2006 Dec; 50(6):1272-7. PubMed ID: 16814458
[TBL] [Abstract][Full Text] [Related]
32. [Elaboration of erythropoietin in cultured cells].
Tazaki H
Hum Cell; 1988 Dec; 1(4):375-81. PubMed ID: 3154021
[TBL] [Abstract][Full Text] [Related]
33. Oxygen-regulated expression of the erythropoietin gene in the human renal cell line REPC.
Frede S; Freitag P; Geuting L; Konietzny R; Fandrey J
Blood; 2011 May; 117(18):4905-14. PubMed ID: 21406725
[TBL] [Abstract][Full Text] [Related]
34. [A case of erythropoietin-producing renal cell carcinoma with polycythemia].
Okuyama M; Nishihara M; Hashimoto H; Kaneko S; Yachiku S
Hinyokika Kiyo; 2002 Sep; 48(9):531-4. PubMed ID: 12402477
[TBL] [Abstract][Full Text] [Related]
35. Erythropoietin-induced secondary polycythemia in a patient with a renal cell carcinoma. A case report.
Nielsen OJ; Jespersen FF; Hilden M
APMIS; 1988 Aug; 96(8):688-94. PubMed ID: 3046641
[TBL] [Abstract][Full Text] [Related]
36. Novel somatic mutations of the VHL gene in an erythropoietin-producing renal carcinoma associated with secondary polycythemia and elevated circulating endothelial progenitor cells.
Rad FH; Ulusakarya A; Gad S; Sibony M; Juin F; Richard S; Machover D; Uzan G
Am J Hematol; 2008 Feb; 83(2):155-8. PubMed ID: 17696210
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin and erythropoietin receptor expression in vestibular schwannoma: potential role in tumor progression.
Diensthuber M; Ilner T; Rodt T; Samii M; Brandis A; Lenarz T; Stöver T
Otol Neurotol; 2007 Jun; 28(4):559-65. PubMed ID: 17429338
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma.
Morris MR; Hughes DJ; Tian YM; Ricketts CJ; Lau KW; Gentle D; Shuib S; Serrano-Fernandez P; Lubinski J; Wiesener MS; Pugh CW; Latif F; Ratcliffe PJ; Maher ER
Anticancer Res; 2009 Nov; 29(11):4337-43. PubMed ID: 20032376
[TBL] [Abstract][Full Text] [Related]
39. Quantitative RT-PCR assays of hypoxia-inducible factor-1alpha, erythropoietin and vascular endothelial growth factor mRNA transcripts in the kidneys with regard to the cause of death in medicolegal autopsy.
Zhao D; Zhu BL; Ishikawa T; Li DR; Michiue T; Maeda H
Leg Med (Tokyo); 2006 Oct; 8(5):258-63. PubMed ID: 16963303
[TBL] [Abstract][Full Text] [Related]
40. Salidroside stimulates the accumulation of HIF-1α protein resulted in the induction of EPO expression: a signaling via blocking the degradation pathway in kidney and liver cells.
Zheng KY; Zhang ZX; Guo AJ; Bi CW; Zhu KY; Xu SL; Zhan JY; Lau DT; Dong TT; Choi RC; Tsim KW
Eur J Pharmacol; 2012 Mar; 679(1-3):34-9. PubMed ID: 22309741
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
